LBF20406HO09: Difference between revisions
No edit summary |
No edit summary |
(No difference)
| |
Revision as of 21:00, 14 April 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8127 |
| LipidMaps | LMFA03060023 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20406HO09 |
| 3R-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid | |
|---|---|
| |
| Structural Information | |
| 3R-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid | |
| |
| 3(R)-HETE | |
| Formula | C20H32O3 |
| Exact Mass | 320.23514489 |
| Average Mass | 320.46628 |
| SMILES | OC(CC=CCC=CCC=CCC=CCCCCC)CC(O)=O |
| Physicochemical Information | |
| 3(R)-HETE enhances the formation of platelet activating factor and release of arachidonic acid from human neutrophils . | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
